title: Cost-effectiveness of interferon alfa 2b and ribavirin in the treatment of chronic hepatitis C.
authors.forename: W R
authors.initials: WR
authors.lastname: Kim
authors.forename: J J
authors.initials: JJ
authors.lastname: Poterucha
authors.forename: J B
authors.initials: JB
authors.lastname: Gross
mesh_terms: D000998:Antiviral Agents / Q000191:economics / Q000627:therapeutic use*; D003362:Cost-Benefit Analysis; D019698:Hepatitis C, Chronic / Q000188:drug therapy* / Q000191:economics; D006801:Humans; D000077190:Interferon alpha-2; D016898:Interferon-alpha / Q000191:economics / Q000627:therapeutic use*; D011994:Recombinant Proteins; D012254:Ribavirin / Q000191:economics / Q000627:therapeutic use*
chemical_list: D000998:Antiviral Agents; D000077190:Interferon alpha-2; D016898:Interferon-alpha; D011994:Recombinant Proteins; D012254:Ribavirin